Skip to content

Improvement of stage 1 hypertension by transcutaneous acupoint electrical stimulation based on mobile health: a randomized controlled pilot trial

Improvement of stage 1 hypertension by transcutaneous acupoint electrical stimulation based on mobile health: a randomized controlled pilot trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR1900002511
Enrollment
Unknown
Registered
2019-08-08
Start date
2019-08-15
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stage 1 Hypertension

Interventions

control group:

Sponsors

Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for stage 1 hypertension; 2. Age between 35 and 65 years old; 3. No language and mental retardation, can successfully answer and fill out the questionnaire; 4. Voluntary signing of informed consent.

Exclusion criteria

Exclusion criteria: 1. Contraindications for the use of acupoint stimulators: wearing a pacemaker and other implanted medical devices; suffering from acute diseases, infectious diseases, malignant tumors;cardiovascular disease, cerebrovascular disease, liver and kidney dysfunction or other malignant diseases; scars, bruises, scratches or inflammation on the skin of the acupuncture points. 2. Hypertension caused by other vascular diseases, primary aldosteronism, other endocrine hypertension, and secondary hypertension caused by other causes. 3. Receiving drugs that affect blood pressure except antihypertensive drugs in previous 2 months such as glucocorticoids, central nervous system inhibitors. 4. Uncontrolled diabetes. 5. Receiving acupuncture treatment in previous 1 month. 6. Drug or alcohol abuse. 7. Pregnant women or women in lactation period. 8. Joined any other study in process.

Design outcomes

Primary

MeasureTime frame
the differences in mean systolic pressure changes;

Secondary

MeasureTime frame
Quality of life evaluation;Weight, body mass index and waist circumference;Physical activity;Heart rate variability;the differences in mean diastolic blood pressure changes;

Countries

China

Contacts

Public ContactCunzhi Liu

School of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine

lcz_tg@126.com+86 15901261692

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026